Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity.

Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, Bosse E, Iqbal J, Hussain MM, Balschun K, Röcken C, Arlt A, Günther R, Hampe J, Schreiber S, Baron JL, Moody DB, Liang TJ, Blumberg RS.

Nat Med. 2012 Jul;18(7):1060-8. doi: 10.1038/nm.2811.

PMID:
22706385
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

NKT cells--an early warning system for HBV infection.

Godfrey DI, Uldrich AP, Baxter AG.

Nat Med. 2012 Jul 6;18(7):1014-6. doi: 10.1038/nm.2853. No abstract available.

PMID:
22772551
[PubMed - indexed for MEDLINE]
3.

Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.

Martinet J, Leroy V, Dufeu-Duchesne T, Larrat S, Richard MJ, Zoulim F, Plumas J, Aspord C.

Hepatology. 2012 Nov;56(5):1706-18. doi: 10.1002/hep.25879. Epub 2012 Aug 27.

PMID:
22707082
[PubMed - indexed for MEDLINE]
4.

PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.

Wang XF, Lei Y, Chen M, Chen CB, Ren H, Shi TD.

J Viral Hepat. 2013 Apr;20 Suppl 1:27-39. doi: 10.1111/jvh.12061.

PMID:
23458522
[PubMed - indexed for MEDLINE]
5.

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.

Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D.

Immunity. 2002 Apr;16(4):583-94.

PMID:
11970881
[PubMed - indexed for MEDLINE]
6.

Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.

Wang Z, Zhu K, Bai W, Jia B, Hu H, Zhou D, Zhang X, Zhang X, Xie Y, Bourgine MM, Michel ML, Lan K, Deng Q.

J Virol. 2014 Mar;88(5):3004-15. doi: 10.1128/JVI.02756-13. Epub 2013 Dec 26.

PMID:
24371056
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.

Lan P, Zhang C, Han Q, Zhang J, Tian Z.

Hepatology. 2013 Jul;58(1):73-85. doi: 10.1002/hep.26339. Epub 2013 May 23.

PMID:
23447417
[PubMed - indexed for MEDLINE]
8.

IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.

Zeng Z, Kong X, Li F, Wei H, Sun R, Tian Z.

J Immunol. 2013 Oct 15;191(8):4184-93. doi: 10.4049/jimmunol.1203449. Epub 2013 Sep 18.

PMID:
24048897
[PubMed - indexed for MEDLINE]
Free Article
9.

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

Kakimi K, Guidotti LG, Koezuka Y, Chisari FV.

J Exp Med. 2000 Oct 2;192(7):921-30.

PMID:
11015434
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G.

Gastroenterology. 2008 May;134(5):1470-81. doi: 10.1053/j.gastro.2008.02.017. Epub 2008 Feb 14.

PMID:
18355815
[PubMed - indexed for MEDLINE]
11.

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C.

Gut. 2009 Jul;58(7):974-82. doi: 10.1136/gut.2008.163600. Epub 2009 Feb 6.

PMID:
19201769
[PubMed - indexed for MEDLINE]
12.

Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.

Li J, Han Y, Jin K, Wan Y, Wang S, Liu B, Liu Y, Lu S, Huang Z.

Virol J. 2011 May 2;8:199. doi: 10.1186/1743-422X-8-199.

PMID:
21535873
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.

Zhou C, Peng G, Jin X, Tang J, Chen Z.

Clin Immunol. 2010 Nov;137(2):190-8. doi: 10.1016/j.clim.2010.07.002. Epub 2010 Aug 7.

PMID:
20692873
[PubMed - indexed for MEDLINE]
14.

Hepatitis B virus-specific CD4 T cell immunity after liver transplantation for chronic hepatitis B.

Luo Y, Lo CM, Cheung CK, Lau GK, Wong J.

Liver Transpl. 2009 Mar;15(3):292-9. doi: 10.1002/lt.21674.

PMID:
19243002
[PubMed - indexed for MEDLINE]
Free Article
15.

Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B.

von Freyend MJ, Untergasser A, Arzberger S, Oberwinkler H, Drebber U, Schirmacher P, Protzer U.

J Viral Hepat. 2011 Mar;18(3):216-26. doi: 10.1111/j.1365-2893.2010.01302.x.

PMID:
20367794
[PubMed - indexed for MEDLINE]
16.

Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.

Qu Z, Liang X, Liu Y, Du J, Liu S, Sun W.

Mol Immunol. 2009 Dec;47(2-3):283-9. doi: 10.1016/j.molimm.2009.09.022. Epub 2009 Oct 4.

PMID:
19804910
[PubMed - indexed for MEDLINE]
17.

Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.

Chen S, Akbar SM, Abe M, Hiasa Y, Onji M.

Clin Exp Immunol. 2011 Oct;166(1):134-42. doi: 10.1111/j.1365-2249.2011.04445.x. Epub 2011 Jul 15.

PMID:
21762128
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV.

Morrey JD, Motter NE, Chang S, Fairman J.

Antiviral Res. 2011 Jun;90(3):227-30. doi: 10.1016/j.antiviral.2011.04.006. Epub 2011 Apr 23.

PMID:
21545812
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].

Zhang HP, Yan HP, Zhang YH, Feng X, Zhao Y, Liao HY, Liu YM, Chen Y, Tan YF, Liu Y.

Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Aug;43(8):690-4. Chinese.

PMID:
20021848
[PubMed - indexed for MEDLINE]
20.

Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.

Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS.

Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3. doi: 10.1053/j.gastro.2008.03.037. Epub 2008 Mar 22.

PMID:
18455515
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk